Exodus Point Capital Management, LP Soleno Therapeutics Inc Transaction History

Exodus Point Capital Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.8 - $1.12 $8,808 - $12,332	-11,011 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$0.97 - $1.32 $751 - $1,023	-775 Reduced 6.58%	11,011 $13,000
Q1 2021 May 17, 2021	BUY	$1.24 - $3.3 $14,614 - $38,893	11,786 New	11,786 $15,000
Q2 2020 Aug 14, 2020	SELL	$1.77 - $4.23 $39,187 - $93,652	-22,140 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.64 - $3.85 $36,309 - $85,239	22,140 New	22,140 $53,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.